Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Care With Guselkumab In Crohn's Disease
NCT07616687Phase 4Recruiting
- Sponsor
- GETAID
- Start
- Jun 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 4 trial of guselkumab in Crohn's disease, sponsored by GETAID. Started Jun 2026; status: recruiting.
02
Drugs
guselkumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07616687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616687.